SimplusDx provides a point‑of‑care immunoassay platform that uses its proprietary D4 technology to deliver laboratory‑grade sensitivity and specificity from a compact, cartridge‑based device. The system’s non‑fouling polymer surface enables rapid, quantitative results from whole‑blood samples without extensive preparation, and integrates securely with health‑record systems for immediate clinical decision‑making.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical laboratories often require centralized equipment, trained personnel, and lengthy turnaround times to perform immunoassays, limiting access to timely diagnostic results in decentralized settings such as primary care offices or remote clinics.
Solution
SimplusDx offers a point‑of‑care immunoassay platform built on its proprietary D4 technology. The system uses a non‑fouling synthetic polymer surface that suppresses background noise from complex samples like whole blood, enabling laboratory‑grade sensitivity and specificity without extensive sample preparation. Tests are performed on a compact, cartridge‑based device that delivers rapid quantitative results on site. Data are captured electronically and can be integrated with existing health‑record systems, allowing clinicians to make immediate, evidence‑based decisions at the bedside.
Target Audience
Primary customers are primary‑care physicians, urgent‑care centers, and community health providers seeking reliable, on‑site diagnostic testing for infectious diseases, biomarkers, and other clinical assays.
Features
- Non‑fouling polymer assay surface that minimizes interference from whole‑blood matrices
- Cartridge format with integrated optical and electrochemical biosensors for multiplexed detection
- Rapid assay workflow delivering results in minutes without the need for bulky instrumentation
- Portable, battery‑operated device designed for use in clinics, pharmacies, or home settings
- Secure digital output compatible with standard health‑IT interfaces for seamless record integration